The following trial balance of Reese Corp. at December 31, 2017 has been properly adjusted except for the income tax expense adjustment.

Reese Corp. Trial Balance December 31, 2017
		Dr.			Cr.
Cash		$	875,000
Accounts receivable (net)			2,695,000
Inventory			2,085,000
Property, plant, and equipment (net)			7,566,000
Accounts payable and accrued liabilities					$	1,761,000
Income taxes payable						654,000
Deferred income tax liability						85,000
Common stock						2,350,000
Additional paid-in capital						3,680,000
Retained earnings, 1/1/17						3,490,000
Net sales and other revenues						13,560,000
Costs and expenses			11,180,000
Income tax expenses			1,179,000
			$25,480,000			$25,480,000

Other financial data for the year ended December 31, 2017: Included in accounts receivable is $1,200,000 due from a customer and payable in quarterly installments of $150,000. The last payment is due December 29, 2019. The balance in the Deferred Income Tax Liability account pertains to a temporary difference that arose in a prior year, of which $20,000 is classified as a current liability. During the year, estimated tax payments of $525,000 were charged to income tax expense. The current and future tax rate on all types of income is 30%. In Reese's December 31, 2017 balance sheet, The current assets total is: ????

The current liabilities total is: ????

The final retained earnings balance is: ????